ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

CELU Celularity Inc

3,11
0,13 (4,36%)
31 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Celularity Inc CELU NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,13 4,36% 3,11 19:09:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,98 2,98 3,3137 3,11 2,98
mais cotações »

Notícias Recentes

Data Hora Fonte Título
24/05/202418:15GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
14/05/202410:15GLOBECelularity Data Published in Journal for ImmunoTherapy of..
22/04/202409:00GLOBECelularity Inc. to Host Investor and Analyst Research &..
19/04/202418:30GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
18/04/202417:30GLOBECelularity Abstract “Emerging Technologies for the..
15/04/202409:00GLOBECelularity Announces Net Sales Trending Ahead of..
08/04/202410:00GLOBECelularity to Present Data Showing Senescent Cell..
26/03/202410:00GLOBECelularity Receives Healthcare Common Procedure Coding..
20/03/202410:15GLOBECelularity Submits Request to U.S. FDA for Orphan Drug..
14/03/202410:15GLOBECelularity CEO to Present on Cell Therapy’s Potential to..
12/03/202410:20GLOBECelularity CEO to Present Keynote Address at 2024 Society..
07/03/202411:35GLOBECelularity to Present Data Showing Cancer Tumor Reduction by..
23/02/202418:10GLOBECelularity Announces 1-for-10 Reverse Stock Split
14/02/202418:05GLOBECelularity’s Tri-layer Decellularized, Dehydrated Human..
01/02/202411:00GLOBECelularity Announces Net Sales Expectations for First..
25/01/202411:00GLOBECelularity and Genting Leaders Comments on Closing $21..
18/01/202415:40GLOBECelularity Releases CEO Letter to Shareholders
04/01/202415:00GLOBECelularity Confirms Commercialization Agreement with..
03/01/202414:00GLOBECelularity Announces Net Sales and Total Revenue..
24/11/202315:15GLOBECelularity Inc. Announces Receipt of Nasdaq Notice Regarding..
18/10/202310:00GLOBECelularity Announces Commercial Biomaterial Products..
07/09/202317:10GLOBECelularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to..
29/08/202310:00GLOBECelularity Announces Multi-Year Research Collaboration..
27/07/202310:07GLOBECelularity Inc. Announces $3 Million Registered Direct..
27/07/202310:00GLOBECelularity and Verséa Ophthalmics Announce Exclusive U.S...
18/07/202310:00GLOBECelularity Human Placental-Derived Advanced Biomaterials..
29/06/202317:05GLOBECelularity Announces Presentation at Upcoming 7th..